国际麻醉学与复苏杂志   2021, Issue (12): 8-8
    
阿片类药物诱发痛觉过敏的机制及防治进展
刘佳运, 王俊1()
1.中国医科大学附属第一医院
Research advances in the mechanism and prevention of opioid‑induced hyperalgesia
 全文:
摘要:

阿片类药物作为传统镇痛药已成为麻醉和镇痛中必不可少的组成部分。但许多临床证据表明,阿片类药物诱发的痛觉过敏(opioid‑induced hyperalgesia, OIH)严重影响患者的术后恢复和生活质量。近年来,关于OIH发生机制的研究不断深入,许多新型药物和治疗手段逐渐更新,但临床上对OIH的诊断与防治仍是一大难题,因此文章从OIH的发生机制、诊断方法、防治措施三方面进行综述,旨在为基础研究和临床应用阿片类药物提供新思路。

关键词: 阿片类药物; 痛觉过敏; 瑞芬太尼; 机制; 防治进展
Abstract:

Opioids, as traditional analgesics, have become an indispensable part of anesthesia and analgesia. However, a lot of clinical evidences show that opioid‑induced hyperalgesia (OIH) seriously affects the postoperative recovery and quality of life of patients. In recent years, the mechanism of OIH has been dissected and many new drugs and treatment methods have been developed. However, the diagnosis and treatment of OIH is still a major concern in clinical practice. Therefore, this review summarized research advances in the mechanism, diagnosis method and prevention and treatment measures of OIH in order to provide new ideas for basic research and guidance for clinical application of opioids.

Key words: Opioids; Hyperalgesia; Remifentanil; Mechanism; Prevention progress